All Pharma News
price-trendAsk Us
GNT0004 Gene Therapy for DMD Results at Myology 2024 Congress

GNT0004 Gene Therapy for DMD Results at Myology 2024 Congress
BUSINESSWIRE
23 Apr 2024
Share Share
Genethon Pursues Strategies for Ensuring Patient Access to Gene Therapies

Genethon Pursues Strategies for Ensuring Patient Access to Gene Therapies
BUSINESSWIRE
29 Feb 2024
Share Share
Genethon Announces Publication of Clinical Trial Results of a Gene Therapy

Genethon Announces Publication of Clinical Trial Results of a Gene Therapy
BUSINESSWIRE
17 Nov 2023
Share Share
Phase 1/2 Trial Results of Genethon’s Gene Therapy for Crigler-Najjar Syndrome

Phase 1/2 Trial Results of Genethon’s Gene Therapy for Crigler-Najjar Syndrome
BUSINESSWIRE
22 Aug 2023
Share Share
GenoTher Biocluster Designation Bolsters French Leadership in Gene Therapy

GenoTher Biocluster Designation Bolsters French Leadership in Gene Therapy
BUSINESSWIRE
10 Jul 2023
Share Share
Genethon Given PRIME Status by EMA for Gene Therapy

Genethon Given PRIME Status by EMA for Gene Therapy
BUSINESSWIRE
07 Mar 2023
Share Share
Genethon Launches Pivotal Trial of Gene Therapy for Crigler-Najjar Syndrome

Genethon Launches Pivotal Trial of Gene Therapy for Crigler-Najjar Syndrome
BUSINESSWIRE
10 Jan 2023
Share Share
Pfizer, Sarepta team with DMD gene therapy makers for analysis

Pfizer, Sarepta team with DMD gene therapy makers for analysis
A. Armstrong FIERCEBIOTECH
18 May 2022
Share Share